Text Size A A A

Acquisitions & Joint Ventures

Tell a Friend Print Home » About Us » Acquisitions & Joint Ventures
Previous Next
  • 2014 Ranbaxy Laboratories Limited

    Acquires Ranbaxy in a US$ 4 billion landmark transaction to create the world’s fifth largest speciality generic pharma company

  • 2013 URL Pharma

    Acquires a comprehensive list of ANDAs and generic products from Takeda Pharmaceuticals

  • 2012 Dusa Pharmaceuticals

    Acquires a developer of a dermatological device used to treat actinic keratoses

  • 2011 MSD

    Signs joint venture with MSD with a focus on emerging markets

  • 2010 Caraco

    Completes 100 % acquisition of Caraco Pharmaceutical Laboratories. Initial stake investment in 1997

  • 2010 Taro

    Acquires majority stake in Taro Pharmaceutical Industries Limited, a multinational generic manufacturer with an established North American presence and a strong franchise in dermatology

  • 2009 Inwood Laboratories, Inc.

    Acquires products from Forest Lab's Inwood Division

  • 2008 Chattem Chemicals Inc.

    Buys Chattem Chemicals, Inc., a manufacturer of controlled substances with an API facility

  • 2005 ABLE LABORATORIES INC

    Acquires the controlled substance manufacturing assets of Able Laboratories Inc.

  • 2005 ICN

    Acquires Alkaloida’s controlled substance API and dosage form manufacturing plant

  • 2004 Women First Health care

    Acquires products from Women's First Healthcare

  • 2004 Phlox Pharma

    Acquires Phlox Pharma, a manufacturer of cephalosporin API, holding USA and European approvals

  • 2002 MJ Pharma

    Completes 100 % acquisition of MJ Pharma , having a plant with US FDA and UK MHRA approvals for oral dosage forms. Initial stake investment in 1996

  • 2000 Pradeep Drug Company

    Acquires Pradeep Drug Company, India

  • 1999 Milmet

    Acquires Milmet Laboratories, India

    initiating entry in ophthalmology

  • 1999 Gujarat Lyka Organics

    Completes 100 % takeover of Gujarat Lyka Organics. Acquire Cephalexin and 7ADCA actives manufacturing site. Initial stake investment in 1996

  • 1998 NATCO PHARMA LTD.

    Acquires select products from Natco Pharma, initiating entry into chest and respiratory therapy areas

  • 1997 TAMILNADU DADHA PHARMACEUTICALS LTD.

    Acquires Tamilnadu Dadha Pharmaceuticals Limited, initiating entry into oncology and gynaecology

  • 1996 KNOLL PHARMA

    Buys an API plant in Ahmednagar, Maharashtra from Knoll Pharma

 

* All logos and trademarks are the property of the relevant trademark owners

Undefined